Bridgeway Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Buy |
76,958
+25,000
| +48% | +$41.3K | ﹤0.01% | 1035 |
|
|
2025
Q1 | $82.1K | Buy |
51,958
+15,000
| +41% | +$23.7K | ﹤0.01% | 1071 |
|
|
2024
Q4 | $124K | Buy |
+36,958
| New | +$124K | ﹤0.01% | 1085 |
|
|
2020
Q2 | – | Sell |
-1,465
| Closed | -$283K | – | 1406 |
|
|
2020
Q1 | $283K | Sell |
1,465
-417
| -22% | -$80.6K | 0.01% | 948 |
|
|
2019
Q4 | $629K | Buy |
1,882
+33
| +2% | +$11K | 0.01% | 885 |
|
|
2019
Q3 | $596K | Buy |
1,849
+20
| +1% | +$6.45K | 0.01% | 877 |
|
|
2019
Q2 | $789K | Hold |
1,829
| – | – | 0.01% | 815 |
|
|
2019
Q1 | $1.03M | Buy |
1,829
+94
| +5% | +$53.1K | 0.01% | 754 |
|
|
2018
Q4 | $515K | Hold |
1,735
| – | – | 0.01% | 991 |
|
|
2018
Q3 | $1.23M | Buy |
+1,735
| New | +$1.23M | 0.01% | 799 |
|